Skip to main content
C

CarboNet

CarboNet's NanoNet platform utilizes programmable flocculants and coagulants to enhance water treatment efficiency across various industries, significantly reducing chemical costs and operational expenses. The technology addresses freshwater scarcity and regulatory challenges by enabling companies to cut treatment costs by up to 50% and minimize toxic chemical usage by 90%.

Vancouver, CanadaFounded 2016361K+ followers
Updated 4 months ago

Funding

$31.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Many industries face increasing freshwater scarcity and stricter regulations, making water treatment more complex and costly. Traditional water treatment methods often rely on large volumes of chemicals, leading to high operational expenses and potential environmental risks. Existing infrastructure may also struggle to meet evolving regulatory demands and production needs.

Solution

CarboNet offers the NanoNet platform, which utilizes AI-designed, programmable flocculants and coagulants to improve water treatment efficiency. This platform enables companies to reduce their water treatment costs by up to 50% and minimize the use of toxic chemicals by up to 90%. CarboNet's adaptive chemistry is designed to be plug-and-play, simplifying operations and increasing team efficiency. The NanoNet platform's molecular targeting capabilities allow for efficient and scalable water treatment solutions across various applications.

Target Audience

CarboNet serves industries such as oil & gas, mining, food & beverage, municipal, pharmaceutical, pulp & paper, construction, and industrial wastewater treatment, targeting ESG, legal/finance, operations/technicians, project managers, and sales/business development roles.

Features

  • AI-designed molecules for targeted water treatment
  • Programmable flocculants and coagulants adaptable to various applications
  • Reduction of chemical usage, specifically PAM (polyacrylamide), by up to 90%
  • Decreased cost-to-treat by up to 50%
  • Plug-and-play system requiring no make-down
  • Increased team efficiency by up to 150%
  • Scalable platform suitable for diverse industries
This profile is AI-generated and may contain inaccuracies.